Ligand efficient tetrahydro-pyrazolopyridines as inhibitors of ERK2 kinase.
Bagdanoff, J.T., Jain, R., Han, W., Poon, D., Lee, P.S., Bellamacina, C., Lindvall, M.(2015) Bioorg Med Chem Lett 25: 3626-3629
- PubMed: 26144345 
- DOI: 10.1016/j.bmcl.2015.06.063
- Primary Citation of Related Structures:  
5BUE, 5BUI, 5BUJ - PubMed Abstract: 
A series of structure based drug design hypotheses and focused screening efforts drove improvements in the potency and lipophilic efficiency of tetrahydro-pyrazolopyridine based ERK2 inhibitors. Elaboration of a fragment chemical lead established a new lipophilic aryl-Tyr interaction resulting in a substantial potency improvement ...